FAKTOR-OPTIONSSCHEIN - HALEON Share Price

Certificat

DE000MG0J117

Market Closed - Börse Stuttgart 07:39:20 04/06/2024 pm IST
10.49 EUR -2.05% Intraday chart for FAKTOR-OPTIONSSCHEIN - HALEON
Current month+0.10%
1 month-6.42%
Date Price Change
04/24/04 10.49 -2.05%
03/24/03 10.71 +2.19%
31/24/31 10.48 -1.78%
30/24/30 10.67 +3.49%
29/24/29 10.31 -3.82%

Delayed Quote Börse Stuttgart

Last update June 04, 2024 at 07:39 pm IST

More quotes

Static data

Product typeExotic Products
Buy / SellCALL
Underlying HALEON PLC
Issuer Morgan Stanley
WKN MG0J11
ISINDE000MG0J117
Date issued 20/03/2024
Strike 215.2 p
Maturity Unlimited
Parity 0.12 : 1
Emission price 10
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 12.22
Lowest since issue 10.31
Spread 0.03
Spread %0.28%

Company Profile

Haleon plc specializes in the research, manufacture and marketing of drugs and consumer pharmaceutical products. Net sales break down by family of products as follows: - oral health products (27.7%; no. 1 worldwide): Sensodyne, Parodontax, Polident, Biotene, Aquafresh brands, etc.; - Pain relief medicines (23.5%; no. 1 worldwide): Panadol, Advil, Voltaren, Excedrin brands, etc.; - medicines for digestive health (18.9%; no. 1 worldwide): TUMS, Nicorette, ENO, Chap Stick, Fenistil, Nexium brands, etc.; - respiratory medicines (15.4%; no. 1 worldwide): Theraflu, Otrivin, Flonase, Contac brands, etc.; - vitamins, minerals and food supplements (14.5%; no. 1 worldwide): Centrum, Emergen-C, Caltrate brands, etc. Net sales are distributed geographically as follows: Europe/Middle East/Africa/Latin America (40.2%), North America (37.1%), and Asia/Pacific (22.7%).
Sector
-
More about the company

Ratings for Haleon plc

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Consensus: Haleon plc

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
3.227 GBP
Average target price
3.62 GBP
Spread / Average Target
+12.18%
Consensus